Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria
jRCT2061250019Recruiting
- Sponsor
- Maruho Co., Ltd.
- Start
- May 2025
- Modality
- Small Molecules
01
Overview
Randomised, double-blind trial in chronic idiopathic urticaria (CIU) comparing EVO756 with Placebo (2 arms). Primary endpoint: Mean change from baseline in UAS7 at Week 12. Started May 2025; status: recruiting.
02
Drugs
EVO756
03
Conditions
chronic idiopathic urticaria (CIU)
Beyond the preview
Go deeper on jRCT2061250019.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2061250019.